Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2021 Filed Jun 17, 2021 21:32 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041579 · doc4.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:33 UTC |
WAN MARK ADirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041584 · doc4.xml · derivative · entry 2 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:33 UTC |
WAN MARK ADirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041584 · doc4.xml · nonDerivative · entry 1 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:31 UTC |
Rosen Howard BDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041575 · doc4.xml · derivative · entry 2 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:31 UTC |
Rosen Howard BDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041575 · doc4.xml · nonDerivative · entry 1 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:28 UTC |
Afable RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041571 · doc4.xml · derivative · entry 2 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:28 UTC |
Afable RichardDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041571 · doc4.xml · nonDerivative · entry 1 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:25 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041560 · doc4.xml · derivative · entry 2 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:25 UTC |
HOFFMAN STEPHEN JDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041560 · doc4.xml · nonDerivative · entry 1 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:23 UTC |
EDWARDS MARK GDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041550 · doc4.xml · derivative · entry 2 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:23 UTC |
EDWARDS MARK GDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041550 · doc4.xml · nonDerivative · entry 1 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 21:22 UTC |
Bozilenko MarinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-21-023825 · doc4.xml · derivative · entry 2 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F3 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months. F3 · derivative.expiration_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 21:22 UTC |
Bozilenko MarinaDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023825 · doc4.xml · nonDerivative · entry 1 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on March 30, 2022, March 30, 2023 and March 30, 2024. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:32 UTC |
Dasu Badri NChief Engineering Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018154 · doc4.xml · derivative · entry 3 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-03-03 F5 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted performance options subject to the satisfaction of share price targets over a performance period from March 3, 2021 to December 31, 2024 (the "Performance Period"), as determined by the Compensation Committee (the "Committee") of the Company's Board of Directors. F6 · derivative.exercise_date: The performance options shall be earned as follows: (i) 33% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $4.00, (ii) an additional 33% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $5.00, and (iii) 34% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $6.00. Once earned, the performance options will vest on the one-year anniversary of the date on which the Committee certified achievement of an applicable price target, so long as the reporting person remains in continuous service through such applicable vesting date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:32 UTC |
Dasu Badri NChief Engineering Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018154 · doc4.xml · derivative · entry 2 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-03-03 F4 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:32 UTC |
Dasu Badri NChief Engineering Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018154 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,757 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on March 3, 2022, March 3, 2023 and March 3, 2024. F3 · balance_after: Balance includes the acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:34 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 68,750 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018155 · doc4.xml · derivative · entry 3 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: Common Stock · 68,750 shares Expires 2031-03-03 F5 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted performance options subject to the satisfaction of share price targets over a performance period from March 3, 2021 to December 31, 2024 (the "Performance Period"), as determined by the Compensation Committee (the "Committee") of the Company's Board of Directors. F6 · derivative.exercise_date: The performance options shall be earned as follows: (i) 33% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $4.00, (ii) an additional 33% of the performance option if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $5.00, and (iii) 34% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $6.00. Once earned, the performance options will vest on the one-year anniversary of the date on which the Committee certified achievement of an applicable price target, so long as the reporting person remains in continuous service through such applicable vesting date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:34 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 137,500 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018155 · doc4.xml · derivative · entry 2 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Underlying: Common Stock · 137,500 shares Expires 2031-03-03 F4 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:34 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantCommon Stock | 68,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018155 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,621 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on March 3, 2022, March 3, 2023 and March 3, 2024. F3 · balance_after: Balance includes acquisition of 4,773 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:30 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 68,750 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018152 · doc4.xml · derivative · entry 3 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: Common Stock · 68,750 shares Expires 2031-03-03 F5 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted performance options subject to the satisfaction of share price targets over a performance period from March 3, 2021 to December 31, 2024 (the "Performance Period"), as determined by the Compensation Committee (the "Committee") of the Company's Board of Directors. F6 · derivative.exercise_date: The performance options shall be earned as follows: (i) 33% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $4.00, (ii) an additional 33% of the performance option if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $5.00, and (iii) 34% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $6.00. Once earned, the performance options will vest on the one-year anniversary of the date on which the Committee certified achievement of an applicable price target, so long as the reporting person remains in continuous service through such applicable vesting date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:30 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 137,500 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018152 · doc4.xml · derivative · entry 2 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Underlying: Common Stock · 137,500 shares Expires 2031-03-03 F4 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:30 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantCommon Stock | 68,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018152 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,597 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on March 3, 2022, March 3, 2023 and March 3, 2024. F3 · balance_after: Balance includes acquisition of 8,548 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:28 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $1.88 | $0.00 |
DisclosureSEC source: 0001209191-21-018151 · doc4.xml · derivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-03-03 F4 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted performance options subject to the satisfaction of share price targets over a performance period from March 3, 2021 to December 31, 2024 (the "Performance Period"), as determined by the Compensation Committee (the "Committee") of the Company's Board of Directors. F5 · derivative.exercise_date: The performance options shall be earned as follows: (i) 33% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $4.00, (ii) an additional 33% of the performance option if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $5.00, and (iii) 34% of the performance options if the Company's average closing stock price measured over a period of thirty consecutive trading days within the Performance Period equals or exceeds $6.00. Once earned, the performance options will vest on the one-year anniversary of the date on which the Committee certified achievement of an applicable price target, so long as the reporting person remains in continuous service through such applicable vesting date. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 20:28 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018151 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,980 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on March 3, 2022, March 3, 2023 and March 3, 2024. F3 · balance_after: Balance includes acquisition of 9,093 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 22:55 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 9,024 | $2.63 | $23,733.12 |
DisclosureSEC source: 0001209191-21-010358 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,299 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 22:53 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 6,775 | $2.63 | $17,818.25 |
DisclosureSEC source: 0001209191-21-010353 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,757 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 22:51 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 8,915 | $2.63 | $23,446.45 |
DisclosureSEC source: 0001209191-21-010350 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593,098 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2021 Filed Feb 12, 2021 22:50 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,052 | $2.63 | $60,626.76 |
DisclosureSEC source: 0001209191-21-010345 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,887 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:33 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 9,414 | $2.59 | $24,382.26 |
DisclosureSEC source: 0001209191-21-008820 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,323 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Balance includes acquisition of 7,717 and 5,255 shares of Common Stock through the Company's Employee Stock Purchase Plan. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:31 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 6,846 | $2.59 | $17,731.14 |
DisclosureSEC source: 0001209191-21-008815 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,532 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes acquisition of 1,265 shares of Common Stock through the Company's Employee Stock Purchase Plan and reflects the correction of the overreporting of 541 ESPP shares purchased on August 31, 2016. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:30 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 9,414 | $2.59 | $24,382.26 |
DisclosureSEC source: 0001209191-21-008811 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,013 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes acquisitions of 4,323 and 4,681 shares of Common Stock through the Company's Employee Stock Purchase Plan and reflects the correction of the overreporting of 2,560 ESPP shares purchased on February 29, 2016. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:29 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 25,059 | $2.59 | $64,902.81 |
DisclosureSEC source: 0001209191-21-008800 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,939 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Balance includes acquisition of 7,241 shares of Common Stock through the Company's Employee Stock Purchase Plan. F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:14 UTC |
Rosen Howard BDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037078 · doc4.xml · derivative · entry 2 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:14 UTC |
Rosen Howard BDirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037078 · doc4.xml · nonDerivative · entry 1 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:17 UTC |
Afable RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037082 · doc4.xml · derivative · entry 2 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:17 UTC |
Afable RichardDirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037082 · doc4.xml · nonDerivative · entry 1 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:15 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037079 · doc4.xml · derivative · entry 2 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:15 UTC |
HOFFMAN STEPHEN JDirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037079 · doc4.xml · nonDerivative · entry 1 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:16 UTC |
EDWARDS MARK GDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037080 · doc4.xml · derivative · entry 2 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:16 UTC |
EDWARDS MARK GDirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037080 · doc4.xml · nonDerivative · entry 1 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:13 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037077 · doc4.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:13 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037077 · doc4.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:12 UTC |
WAN MARK ADirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-20-037075 · doc4.xml · derivative · entry 2 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 16, 2020 Filed Jun 16, 2020 23:12 UTC |
WAN MARK ADirector
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037075 · doc4.xml · nonDerivative · entry 1 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 15, 2020 Filed Jun 15, 2020 22:39 UTC Amendment |
ADAMS ADRIANDirector
|
PurchaseCommon Stock | 100,000 | $1.29 | $128,900.00 |
DisclosureSEC source: 0001209191-20-036749 · doc4a.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,750 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.27 to $1.30 on June 15, 2020. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 15, 2020 Filed Jun 15, 2020 22:01 UTC |
ADAMS ADRIANDirector
|
PurchaseCommon Stock | 100,000 | $1.29 | $128,900.00 |
DisclosureSEC source: 0001209191-20-036729 · doc4.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,750 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.27 to $1.30 on June 15, 2020. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 15, 2020 Filed Jun 15, 2020 22:00 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
PurchaseCommon Stock | 7,547 | $1.33 | $10,035.25 |
DisclosureSEC source: 0001209191-20-036726 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,757 F1 · balance_after: Balance includes non-reportable acquisition of 8,318 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:15 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 5,613 | $1.71 | $9,598.23 |
DisclosureSEC source: 0001209191-20-009168 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,654 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:14 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 7,924 | $1.71 | $13,550.04 |
DisclosureSEC source: 0001209191-20-009163 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 604,983 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:14 UTC |
Hamel Lawrence GChief Development Officer
|
Tax withholdingCommon Stock | 5,613 | $1.71 | $9,598.23 |
DisclosureSEC source: 0001209191-20-009164 · doc4.xml · nonDerivative · entry 1 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,769 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.